Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy

Published:2020-12-30 Issue: Volume: Page:1-18
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Rodríguez-Márquez Esther¹²³,Meumann Nadja²³,Büning Hildegard²³⁴⁵

Affiliation:

1. Universidad Autónoma De Madrid, Madrid, Spain

2. Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany

3. REBIRTH Research Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany

4. Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

5. German Center for Infection Research (DZIF, Partner Site Hannover-Braunschweig, Germany

Funder

the Universidad Autónoma de Madrid

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1865303

Reference146 articles.

1. Adenovirus-Associated Defective Virus Particles

2. Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics.

3. Site-specific integration by adeno-associated virus.

4. Recombinant adeno-associated virus vectors in the treatment of rare diseases

5. Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery of CRISPR/Cas9 system by AAV as vectors for gene therapy;Gene;2024-11

2. Leukocyte cell-derived chemotaxin 2 (LECT2) regulates liver ischemia–reperfusion injury;Liver Research;2024-09

3. Investigating Fabry disease - some lessons learned;Rare Disease and Orphan Drugs Journal;2024-01-23

4. Genome editing without nucleases confers proliferative advantage to edited hepatocytes and corrects Wilson disease;JCI Insight;2023-11-08

5. Discovering human cell‐compatible gene therapy virus variants via optimized screening in mouse models;Cell Proliferation;2023-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3